Evaluation and Treatment of Idiopathic Pulmonary Fibrosis


December 19th, 2014 - December 19th, 2017
1.00 AMA PRA Category 1 Credit Hours

Description

Today on MedNet21, we're going to discuss Evaluation and Treatment of Idiopathic Pulmonary Fibrosis.
The webcast is no longer available.
Post-Test taking for this webcast is no longer available.

Dates and Times

End Date: 12/19/2017

Objectives

As a result of this educational activity, webcast participants will be able to: RECOMMEND non-pharmacologic treatment to patients with IPF; ADVISE patients about risks and benefits of newly approved medications for IPF; DESCRIBE the approach to evaluation of a patient with ILD; REVIEW the diagnostic approach to patients with idiopathic pulmonary fibrosis.

Webcasts Files

File Link

Disclosure Information for Planning Committee Members and Speakers

Download

Evaluation and Treatment of IPF - 2

Download

Evaluation and Treatment of IPF - 4

Download

Speakers

  • Dr. James Allen, MD
    • Evaluation and Treatment of Idiopathic Pulmonary Fibrosis
  • Dr. Nitin Bhatt, MD
    • Evaluation and Treatment of Idiopathic Pulmonary Fibrosis

Accreditation

The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians

The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.